Bruno Dubois
Impact in
- Psychiatry and Mental health top 0.01%
- Dementia and Cognitive Impairment Research
- Neurology top 0.05%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Dementia and Cognitive Impairment Research 174
- Physiology 121
- Alzheimer's disease research and treatments 117
- Co-authors
- Howard Feldman (11 shared papers)Steven T. DeKosky (4 shared papers)Ronald C. Petersen (5 shared papers)María C. Carrillo (5 shared papers)William J. Jagust (3 shared papers)Nick C. Fox (5 shared papers)David M. Holtzman (3 shared papers)Marilyn S. Albert (3 shared papers)
- Journals
- Alzheimer s & Dementia (62 papers)Journal of Alzheimer s Disease (24 papers)Neurobiology of Aging (15 papers)Neurology (15 papers)Cortex (13 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Bruno Dubois
403 papers receiving 39.2k citations
Bruno Dubois's Hit Papers
Peers
Comparison fields: 5 of 203
- Psychiatry and Mental health 15.8k
- Neurology 4.7k
- Cognitive Neuroscience 9.8k
- Physiology 10.8k
- Biological Psychiatry 846
Countries citing papers authored by Bruno Dubois
This map shows the geographic impact of Bruno Dubois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Dubois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Dubois more than expected).
Fields of papers citing papers by Bruno Dubois
This network shows the impact of papers produced by Bruno Dubois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Dubois. The network helps show where Bruno Dubois may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruno Dubois, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 420 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Hit paper breakdown → | 2011 | 7417 |
| 2 | Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria Hit paper breakdown → | 2007 | 3199 |
| 3 | The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease Hit paper breakdown → | 2013 | 2165 |
| 4 | A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers Hit paper breakdown → | 2016 | 1210 |
| 5 | Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization Hit paper breakdown → | 2003 | 1060 |
| 6 | The Mental Representation of Hand Movements After Parietal Cortex Damage Hit paper breakdown → | 1996 | 672 |
| 7 | Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group Hit paper breakdown → | 2021 | 641 |
| 8 | Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation Spectrum Hit paper breakdown → | 1999 | 544 |
| 9 | Direct Evidence for a Parietal-Frontal Pathway Subserving Spatial Awareness in Humans Hit paper breakdown → | 2005 | 503 |
| 10 | 2007 | 441 | |
| 11 | 2005 | 425 | |
| 12 | A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease Hit paper breakdown → | 2017 | 417 |
| 13 | A Phase II Trial of Tideglusib in Alzheimer's Disease Hit paper breakdown → | 2015 | 417 |
| 14 | Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges Hit paper breakdown → | 2015 | 397 |
| 15 | 2004 | 388 | |
| 16 | Implementation of subjective cognitive decline criteria in research studies Hit paper breakdown → | 2016 | 387 |
| 17 | On the path to 2025: understanding the Alzheimer’s disease continuum Hit paper breakdown → | 2017 | 385 |
| 18 | Early and protective microglial activation in Alzheimer’s disease: a prospective study using18F-DPA-714 PET imaging Hit paper breakdown → | 2016 | 380 |
| 19 | 2014 | 357 | |
| 20 | Drug development in Alzheimer’s disease: the path to 2025 Hit paper breakdown → | 2016 | 352 |
About Bruno Dubois
Bruno Dubois is a scholar working on Psychiatry and Mental health, Physiology, Cognitive Neuroscience, Neurology and Molecular Biology, having authored 420 papers that have together received 40.1k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (174 papers), Alzheimer's disease research and treatments (117 papers), Functional Brain Connectivity Studies (40 papers), Memory and Neural Mechanisms (29 papers), Neural and Behavioral Psychology Studies (26 papers), Spatial Neglect and Hemispheric Dysfunction (22 papers), Neurological Disease Mechanisms and Treatments (21 papers) and Neurobiology of Language and Bilingualism (20 papers). The work is most often cited by research in Psychiatry and Mental health (15.8k citations), Neurology (4.7k citations), Cognitive Neuroscience (9.8k citations), Physiology (10.8k citations) and Biological Psychiatry (846 citations). Bruno Dubois has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Howard Feldman, Steven T. DeKosky, Ronald C. Petersen, María C. Carrillo, William J. Jagust, Nick C. Fox, David M. Holtzman, Marilyn S. Albert, Creighton H. Phelps and Dennis W. Dickson. Their work appears in journals such as Alzheimer s & Dementia, Journal of Alzheimer s Disease, Neurobiology of Aging, Neurology and Cortex.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.